The RARE Corporate Alliance™ is a collaboration of rare disease stakeholders committed to helping advance efforts benefiting the rare disease community and its constituents.
The goal of the RARE Corporate Alliance™ is to help facilitate collaboration and an information exchange among patients, patient advocacy organizations, health related organizations, industry, payers, policy makers and regulatory agencies. Only with all stakeholders at the table with an open cooperative “we-can” spirit, will we effectively address issues facing the rare disease community.
Membership is open to pharmaceutical and biotech companies, industry and academia. Associate membership is available for payors, policy makers and regulatory agencies.